The ISSCR is delighted to announce Hideyuki Okano, MD, PhD, Distinguished Professor and Director of the Keio University Regenerative Medicine Research Center, as well as former Dean of the Keio University School of Medicine in Japan, as its President. His term of office begins today.

A new technology that uses clinical MRI machines to image metabolic activity in the brain could give researchers and clinicians unique insight into brain function and disease, researchers at the University of Illinois at Urbana-Champaign report. The non-invasive, high-resolution metabolic imaging of the whole brain revealed differences in metabolic activity and neurotransmitter levels among brain regions; found metabolic alterations in brain tumors; and mapped and characterized multiple sclerosis lesions — with patients only spending minutes in an MRI scanner.

A collaborative multidisciplinary team of researchers from the Perelman School of Medicine and New York University has developed a miniature chip that could transform how blood cancer treatments are tested and tailored for patients. “This device addresses a significant gap in preclinical research, offering an advanced tool for studying CAR T cell therapy’s dynamic and multifaceted responses to leukemia,” says Saba Ghassemi of the Perelman School of Medicine at the Unviersity of Pennsylvania.

BUFFALO, NY – July 1, 2025 – A new review was published in Volume 16 of Oncotarget on June 17, 2025, titled “Optimizing enfortumab vedotin plus pembrolizumab therapy.”